Broncus Tech raises $29.5M for emphysema treatment
Broncus Technologies Inc., a Mountain View, Calif.-based developer of an investigational bronchoscopic procedure for the treatment of emphysema, has raised $29.5 million in Series F funding. Abingworth Management, Japan Asia Investment Co., and Saratoga Ventures were joined by return backers Biomedical Sciences Investment Fund, Bio-Star, HBM BioCapital, HBM BioVentures, Menlo Ventures, Pac-Link, Rockport Ventures and Sightline Ventures. The company has now raised around $73 million in total VC funding since its 1997 inception, including a $20 million Series D round in 2002 at a post-money valuation of approximately $78 million. (Source: PE wire)
Next Story: Ad Infuse raises $6M to help deliver mobile ads
Previous Story: PortAuthority Tech, a data security company, raises $18M
